Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study

Background: Cognitive and motor task performance in premanifest Huntington's disease (HD) gene-carriers is often within normal ranges prior to clinical diagnosis, despite loss of brain volume in regions involved in these tasks. This indicates ongoing compensation, with the brain maintaining fun...

Full description

Bibliographic Details
Main Authors:	Stefan Klöppel, Sarah Gregory, Elisa Scheller, Lora Minkova, Adeel Razi, Alexandra Durr, Raymund A.C. Roos, Blair R. Leavitt, Marina Papoutsi, G. Bernhard Landwehrmeyer, Ralf Reilmann, Beth Borowsky, Hans Johnson, James A. Mills, Gail Owen, Julie Stout, Rachael I. Scahill, Jeffrey D. Long, Geraint Rees, Sarah J. Tabrizi
Format:	Article
Language:	English
Published:	Elsevier 2015-10-01
Series:	EBioMedicine
Subjects:	Huntington's disease Preclinical Neural compensation MRI Cognitive Motor
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396415300967

Similar Items

Detection of motor changes in Huntington’s disease using dynamic causal modeling
by: Lora eMinkova, et al.
Published: (2015-11-01)

Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
by: Eileanoir B. Johnson, et al.
Published: (2021-03-01)

Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington’s Disease
by: Eileanoir B. Johnson, et al.
Published: (2017-10-01)

Altered Intracortical T1-Weighted/T2-Weighted Ratio Signal in Huntington’s Disease
by: Christopher D. Rowley, et al.
Published: (2018-11-01)

Working Memory-Related Effective Connectivity in Huntington’s Disease Patients
by: Jacob Lahr, et al.
Published: (2018-06-01)

Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease
by: Nina M. Mansoor, et al.
Published: (2021-04-01)

Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
by: Naoki Masuda, et al.
Published: (2008-06-01)

Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
by: Amber L. Southwell, et al.
Published: (2015-04-01)

Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study
by: Govinda R. Poudel, et al.
Published: (2015-02-01)

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease
by: Lora Minkova, et al.
Published: (2018-01-01)

Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
by: Swati Sathe, et al.
Published: (2021-08-01)

Diagnosing Juvenile Huntington’s Disease: An Explorative Study among Caregivers of Affected Children
by: Mayke Oosterloo, et al.
Published: (2020-03-01)

Refining the diagnosis of Huntington Disease: The PREDICT-HD study
by: Kevin M Biglan, et al.
Published: (2013-04-01)

Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington’s Disease Using the Enroll-HD Global Platform
by: Alexander L. Symonds, et al.
Published: (2021-05-01)

The development of PAT‐HD: A co‐designed tool to promote physical activity in people with Huntington’s disease
by: Una Jones, et al.
Published: (2021-04-01)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
by: Natalia P. Rocha, et al.
Published: (2018-11-01)

International Guidelines for the Treatment of Huntington's Disease
by: Anne-Catherine Bachoud-Lévi, et al.
Published: (2019-07-01)

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
by: Nicola Pavese, et al.
Published: (2010-02-01)

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
by: Marios Politis, et al.
Published: (2015-11-01)

Attempted and successful compensation in preclinical and early manifest neurodegeneration – a review of task fMRI studies
by: Elisa eScheller, et al.
Published: (2014-09-01)

Mammals of the Huntington Reservoir, Huntington and Wells Counties, Indiana
by: Reising, Johnny W.
Published: (2011)

Clinical Manifestation of Juvenile and Pediatric HD Patients: A Retrospective Case Series
by: Jannis Achenbach, et al.
Published: (2020-06-01)

Association between caffeine intake and age at onset in Huntington's disease
by: Clémence Simonin, et al.
Published: (2013-10-01)

Huntington’s chorea and schizophrenia : amino acids in thalamus
by: Buchanan, Janet Ann
Published: (2010)

Juvenile Huntington disease in Argentina
by: Emilia Mabel Gatto, et al.
Published: (2015-01-01)

The use of olanzapine in Huntington disease accompanied by psychotic symptoms
by: Cafer Alhan, et al.
Published: (2014-06-01)

Physiotherapy in Huntington’s disease
by: Hanne Ludt Fossmo, et al.
Published: (2013-01-01)

MRI findings in juvenile Huntington's disease
by: Patrick Arraj, BS, et al.
Published: (2021-01-01)

Huntington Hastalığında Dikkat Fonksiyonlarının Değerlendirilmesi
by: Murat Gültekin, et al.
Published: (2017-12-01)

A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington’s Disease
by: Peter A. Wijeratne, et al.
Published: (2021-08-01)

The type of concurrent task affects dual-task performance in Huntington's disease
by: Vaportzis, Ria, et al.
Published: (2019)

Internal consistency of a Brazilian version of the unified Huntington's disease rating scale Consistência interna da versão brasileira da escala unificada para avaliação da doença da Huntington
by: Vitor Tumas, et al.
Published: (2004-12-01)

Juvenile Huntington's disease confirmed by genetic examination in twins Doença de Huntington juvenil confirmada por exame genético em gêmeas
by: GILBERTO LEVY, et al.
Published: (1999-09-01)

Huntington’s disease: The Indian perspective
by: Srinivas Raju, et al.
Published: (2021-01-01)

Unawareness of deficits in Huntington's disease
by: McGlynn, Susan Mary, 1960-
Published: (1989)

Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study
by: Jane S Paulsen, et al.
Published: (2014-04-01)

A molecular approach to Huntington disease in Southern Africa
by: Greenberg, Leslie J H L
Published: (2017)

Exploring computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD): protocol for a randomised feasibility study
by: Emma Yhnell, et al.
Published: (2018-02-01)

Huntington Disease in Asia
by: Miao Xu, et al.
Published: (2015-01-01)

Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington’s Disease: A Survey Conducted by the European Huntington Association
by: Filipa Júlio, et al.
Published: (2021-08-01)